Found: 4
Select item for more details and to access through your institution.
Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0303450
- By:
- Publication type:
- Article
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 54, n. 2, p. 515, doi. 10.1093/jac/dkh356
- By:
- Publication type:
- Article
Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis.
- Published in:
- ENT: Ear, Nose & Throat Journal, 2003, v. 82, n. 8, p. 576, doi. 10.1177/014556130308200812
- By:
- Publication type:
- Article
Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition.
- Published in:
- Clinical Infectious Diseases, 2000, v. 31, n. 5, p. 1166, doi. 10.1086/317425
- By:
- Publication type:
- Article